ADC2021-long
  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers
Menu
  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers

Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md

Annual Dialysis Conference > Posters > Adult > Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md
Adult
January 13, 2022 By mimhav
1090 2022 Adult
Previous
Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD
Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD
Next
Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS
Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS

Presented in cooperation with

Contact

314-516-8419
Conferences@mimh.edu

  • Program
    • Program 2023
  • Accreditation 2023
    • Accreditation 2023
    • COI Information
  • Scholarships – Case Submissions
  • Exhibitors and Sponsors
    • ADC 2023 Prospectus
    • Exhibitor and Sponsor Registration
    • ADC 2023 Exhibitors
  • Submit Your Abstract
    • Submit Your Abstract
  • Program Organizers